This Laboratory Pill Analysis Program is directed by Ecstasydata.org with support from DanceSafe, MAPS, Erowid, and the Promind Foundation. Its purpose is to monitor the US ecstasy market and provide the general public information on the contents of illicit "ecstasy" tablets. This not only helps ecstasy users avoid ingesting pills that contain more dangerous substances, but educates researchers, health care professionals, treatment providers and policy makers on the variety of drugs people are being exposed to who are taking what they think is MDMA.

The laboratory we contract with in Sacramento, California, is licensed by the DEA to handle anonymously-sent controlled substances. They are a private lab and are not affiliated with DanceSafe, ecstasydata.org, MAPS, or the Promind Foundation. They provide this service to us for a fee of $100 per analysis and perform qualitative testing only.

The United States DEA currently forbids quantitative anonymous testing. The lab is not allowed to test for the number of milligrams in each pill. They are only allowed to identify what ingredients are in the pill (but not how much). Pills with more than one active ingredient will have their ingredients listed in order of relative amount, with the dominant ingredient listed first.

All tests are performed using gas chromatography (GCMS). The laboratory is able to identify the presence of MDMA, MDA, MDE, MBDB, MDOH, PCP, amphetamine, methamphetamine, ketamine, 2-CB, DOB, 4-MTA, caffeine, ephedrine, dextromethorphan (DXM) and just about every other known drug.

Contact Us!